Open-label Comparative Cohort Non-interventional Epidemiological Study of the Efficacy and Safety of Enzyme Replacement Therapy in Russian Patients with Fabry Disease
Latest Information Update: 21 Mar 2025
At a glance
- Drugs Agalsidase alfa (Primary) ; Agalsidase beta (Primary) ; Agalsidase beta (Primary)
- Indications Fabry's disease
- Focus Therapeutic Use
- Acronyms FAVORIT
- Sponsors Petrovax Pharm
- 21 Mar 2025 New trial record